Infectious bursal disease (IBD) or gumboro is one of the most important immunosuppressive chicken diseases with a significant economic impact by direct and indirect economic losses. Since its first report at the early 1960s in the United States, IBD has become widely distributed all over the world and endemic in the major poultry producer areas. In addition to its zootechnical impact and its role in the development of secondary infections, it may affect the immune response of the chicken and induce suboptimal vaccine responses. Although first observed more than 50 years ago and despite major research efforts, IBD is still a big threat for poultry producers and the control of IBD represents a challenge to the global poultry industry. To fight this disease, the right vaccination strategy is a key concern for poultry veterinarians all over the world. The high resistance of Infectious bursal disease virus (IBDV) to the environment, its complex interaction with the immune system, which causes a high mutation rate that may give rise to viruses with a modified antigenicity or increased virulence are why vaccination programs must be reviewed, evaluated and challenged periodically to ensure proper protection against IBD. During this one-hour educational webinar, learn about the characteristics of the different IBD pathotypes, the most important changes of IBD since its appearance and the need to revise and optimize your IBD protection plan.
WHAT YOU’LL LEARN:
-
Which are the current IBDV pathotypes and its different characteristics
-
Which have been the most relevant changes of IBDV since its appearance and what scientific evidences support the continuous evolution of IBDV
-
Why there is need to review, evaluate and challenge periodically the IBD vaccination programs
This webinar is sponsored by Elanco and presented by WATT Global Media.
Speaker Info:
Dr. Guillermo Zavala is the founder of Avian Health International. Dr Zavala holds a DVM and a specialty in poultry production from the University of Mexico; a Master of Science, a Master of Avian Medicine, and a PhD in medical microbiology from the University of Georgia. He has worked in broiler and breeding companies, vaccine companies, one diagnostic laboratory, two academic institutions and as Adjunct Professor at the Department of Population Health, University of Georgia. His field of research is in applied virology (CIAV, IBDV, tumor viruses, ILT, enteric viruses and fowl adenovirus). He has 32 publications in peer-reviewed journals.
Dr. Natalia Majo holds a DVM and a PhD in Veterinary Medicine from the Autonomous University of Barcelona. She also holds an European Diplomate in Veterinary Pathology (ECVP) and in Poultry Veterinary Science (ECPVS). She is currently Associate Professor in the Department of Animal Health in the Veterinary School of the Autonomous University of Barcelona and Research Leader of the Avian Virus Research Group in CReSA (Research Center on Animal Health). Dr Majo has coordinated several national and international projects mainly related to avian viral diseases. She has published more than 80 peer-reviewed papers mainly related to poultry diseases such as infectious bursal disease, avian influenza, and avian infectious bronchitis.
Dr. Guillermo Zavala is the founder of Avian Health International. Dr Zavala holds a DVM and a specialty in poultry production from the University of Mexico; a Master of Science, a Master of Avian Medicine, and a PhD in medical microbiology from the University of Georgia. He has worked in broiler and breeding companies, vaccine companies, one diagnostic laboratory, two academic institutions and as Adjunct Professor at the Department of Population Health, University of Georgia. His field of research is in applied virology (CIAV, IBDV, tumor viruses, ILT, enteric viruses and fowl adenovirus). He has 32 publications in peer-reviewed journals.